Lilium Jet Deliveries on Track for 2026, Manned Flight Soon
Ticker: LILMF · Form: 6-K · Filed: Jul 17, 2024 · CIK: 1855756
| Field | Detail |
|---|---|
| Company | Lilium N.V. (LILMF) |
| Form Type | 6-K |
| Filed Date | Jul 17, 2024 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $113 million, $20.6 million, $20.2 m, $0.25 million, $0.1 m |
| Sentiment | neutral |
Sentiment: neutral
Topics: delivery-schedule, regulatory-certification, flight-test
TL;DR
Lilium confirms 2026 deliveries for its jet, manned flight tests imminent.
AI Summary
On July 17, 2024, Lilium N.V. confirmed its delivery schedule for its Lilium Jet, with first customer deliveries still expected in 2026, contingent on regulatory certification. The company also anticipates the first manned flight test of the Lilium Jet to occur in the coming weeks.
Why It Matters
This confirmation provides clarity on Lilium's production timeline, potentially impacting investor confidence and the competitive landscape for electric vertical take-off and landing (eVTOL) aircraft.
Risk Assessment
Risk Level: medium — The confirmation is subject to regulatory certification and successful testing, which are inherently uncertain and can lead to delays.
Key Numbers
- 2026 — First Customer Deliveries (The confirmed target year for Lilium to begin delivering its Lilium Jet to customers.)
Key Players & Entities
- Lilium N.V. (company) — The company filing the report and confirming its delivery schedule.
- Lilium Jet (company) — The electric vertical take-off and landing (eVTOL) aircraft being developed by Lilium.
- July 17, 2024 (date) — The date of the press release announcing the confirmation.
- 2026 (date) — The expected year for first customer deliveries of the Lilium Jet.
FAQ
What is the expected timeline for the first manned flight test of the Lilium Jet?
The filing states that Lilium currently expects the first manned flight test of the Lilium Jet to occur in the coming weeks.
Are there any conditions attached to the 2026 delivery schedule?
Yes, the delivery schedule is subject to applicable regulatory certification requirements.
What is the primary purpose of this 6-K filing?
The filing is to report a press release published by Lilium N.V. on July 17, 2024, regarding its program review and delivery schedule.
What is the company's principal executive office address?
The company's principal executive office is located at Galileostraße 335, 82131 Gauting, Germany.
Has Lilium N.V. changed its name previously?
Yes, the company was formerly known as Lilium B.V. and changed its name on April 8, 2021.
Filing Stats: 1,275 words · 5 min read · ~4 pages · Grade level 12.1 · Accepted 2024-07-17 07:30:07
Key Financial Figures
- $113 million — apital raise resulting in approximately $113 million of gross proceeds after giving effect t
- $20.6 million — gregate gross proceeds of approximately $20.6 million. The Company's sales to Aceville and Me
- $20.2 m — lted in gross proceeds of approximately $20.2 million, $0.25 million and $0.1 million,
- $0.25 million — roceeds of approximately $20.2 million, $0.25 million and $0.1 million, respectively, after g
- $0.1 m — mately $20.2 million, $0.25 million and $0.1 million, respectively, after giving effec
- $1.05 — Class A Shares at an exercise price of $1.05 per Class A Share (the "Aceville Pre-Fu
- $1.00 — ), for which Aceville partially prepaid $1.00 per Class A Share for an aggregate prep
- $24 million — aggregate prepay price of approximately $24 million against the total exercise price of the
Filing Documents
- tm2419643d1_6k.htm (6-K) — 19KB
- tm2419643d1_ex99-1.htm (EX-99.1) — 14KB
- tm2419643d1_ex99-2.htm (EX-99.2) — 272KB
- tm2419643d1_ex99-3.htm (EX-99.3) — 3KB
- tm2419643d1_ex99-3img01.jpg (GRAPHIC) — 150KB
- 0001104659-24-080335.txt ( ) — 517KB
Forward-Looking Statements
Forward-Looking Statements The information contained in this Report on Form 6-K and the Exhibits attached hereto contain certain forward-looking statements within the meaning of the U.S. federal securities laws, including, but not limited to, statements regarding (i) Lilium N.V.'s and its subsidiaries (collectively, the "Lilium Group") proposed business and business model, including the ongoing development of its support and services organization, (ii) the markets and industry in which the Lilium Group operates or intend s to operate, (iii) the manner in which Lilium expects to continue to fund its operations, (iv) the Lilium Group's progress towards type certification (and type certificate validation) of its Lilium Jet with EASA and the FAA, including development of an engineering simulator to support this process, and (v) the production, certification, and flight testing program, delivery schedule and related timelines for the Lilium Jet. These forward-looking statements generally are identified by the words "anticipate," "believe," "could," "expect," "estimate," "future," "intend," "may," "on track," "plan," "project," "should," "strategy," "will," "would" and similar expressions. Forward-looking expectations with respect to future events and are based on assumptions a nd are subject to risks and uncertainties that are subject to change at any time. Actual events or results may differ materially from those contained in the forward-looking statements. Factors that could cause actual future events to differ materially from the
forward-looking statements in this Report on Form 6-K and the Exhibits attached hereto include
forward-looking statements in this Report on Form 6-K and the Exhibits attached hereto include (but are not limited to) the risk that Lilium experiences delays in obtaining, or fails to obtain, type certification for the Lilium Jet in applicable jurisdictions and/or the other markets that it conducts or intends to conduct sales activities, as well as those risks and uncertainties discussed in Lilium N.V.'s filings with the U.S. Securities and Exchange Commission (the "SEC"), including in the section titled "Risk Factors" in Lilium N.V.'s Annual Report on Form 20-F for the year ended December 31, 2023, on file with the SEC, and similarly titled sections in Lilium's other SEC filings, all of which are available at www.sec.gov. Forward-looking statements speak only as of the date they are made. You are cautioned not to put undue reliance on forward-looking statements, and the Lilium Group assumes no obligation to, and does not intend to, update, or revise these forward-looking statements, whether as a result of new information, future events or otherwise.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Dated: July 17, 2024 Lilium N.V. By: /s/ Klaus Roewe Name: Klaus Roewe Title: Chief Executive Officer and Executive Director EXHIBIT INDEX Exhibit Number Description of Document 99.1 Lilium Reaffirms 2026 Target for First Customer Deliveries and Provides Additional Detail on Testing Program 99.2 Updated Risk Factors 99.3 Corporate Presentation Update